Martin Akerman
Company: Envisagenics
Job title: CTO
Seminars:
AI-Driven Discovery of Safe, Tumor-Specific Immunotherapies Through the Lenses of RNA Splicing 1:00 pm
Using AI to analyze RNA-seq data and prioritize neoepitopes encoded by tumor-specific splicing isoforms Delve into the use of biopsies from different cohorts of patients with tumor vs. normal tissues to avoid off-target effects Validated novel neoepitopes predicted with AI through a case study in triple negative breast cancerRead more
day: Day Two
Chair’s Closing Remarks 4:30 pm
day: Day One